dequalinium has been researched along with 1,2-dielaidoylphosphatidylethanolamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, Y; Choi, JS; Green, ES; Han, J; Jung, MK; Ko, KS; Lee, S; Mun, JY; Song, SJ | 1 |
1 other study(ies) available for dequalinium and 1,2-dielaidoylphosphatidylethanolamine
| Article | Year |
|---|---|
Dequalinium-based functional nanosomes show increased mitochondria targeting and anticancer effect.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Dequalinium; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Fatty Acids, Monounsaturated; Flow Cytometry; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Microscopy, Confocal; Microscopy, Electron, Transmission; Mitochondria; Nanomedicine; Nanoparticles; Neoplasms; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Reactive Oxygen Species; Technology, Pharmaceutical | 2018 |